Counselors in West Warwick, RI Accepting Medicare

24 Counselors found. Showing 21 - 24

Jermaine Porter Counselor - Mental Health Medicare: Medicare Enrolled Practice Location: 186 Providence St, West Warwick, RI 02893 Phone: 401-615-2800

Sarah Corriveau Owens, MSED, LMHC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 215 Washington St, West Warwick, RI 02893 Phone: 401-822-1360

Mrs. Anne Marie Bood, LICSW Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 84 Birchwood Ln, West Warwick, RI 02893 Phone: 781-281-8544

Mrs. Jennifer Lynn Rocha, LCDP Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 1 James P Murphy Ind Hwy, West Warwick, RI 02893 Phone: 401-615-0648    Fax: 401-615-9540

News Archive

'Supercharged' immune cells could help fight cancer

A type of 'supercharged' immune cell could be mass-produced to help fight cancer.

Researchers identify key step in maturation pathway of telomerase

The Stowers Institute's Baumann Lab has discovered an important step in the maturation pathway of telomerase, the enzyme that replenishes the sequences that are lost at chromosome ends with every cell division.

Brain regions decide where we look

Scientists have found the brain regions that decide where we look, and where to direct our eyes when we're faced with a difficult choice, such as looking someone straight in the eye or looking away.

Proteomics research market estimated to reach $1.6 billion this year

Pharmaceutical companies and diagnostics companies spend billions developing new drugs and tests, and this is translating into a sizeable market for the instruments that can assist them. This according to Kalorama Information, a healthcare market research publisher. Kalorama Information said instruments such as mass spectrometry, electrophoresis and liquid chromatography that can assist in the identification of drug targets and the validation of biomarkers, are in demand.

Merck's VICTRELIS receives European CHMP positive opinion for treatment of chronic HCV genotype 1 infection

Merck, today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion under accelerated assessment recommending approval of the investigational medicine VICTRELIS (boceprevir) for the treatment of chronic hepatitis C virus genotype 1 infection, in combination with peginterferon alfa and ribavirin, in adult patients with compensated liver disease who are previously untreated or who have failed previous therapy.

Read more Medical News

› Verified 7 days ago

• 1
• 2(current)